Medicare Enrolled
Dr. Omid Omidvar, M.D.
Neurology · Los Alamitos, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Omidvar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Omidvar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Omidvar
Dr. Omid Omidvar is a neurology specialist in Los Alamitos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Omidvar performed 2,577 Medicare services across 1,418 unique beneficiaries.
Between the years covered by Open Payments, Dr. Omidvar received a total of $17,136 from 69 pharmaceutical and/or device companies across 593 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Omidvar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in CA
$17,136 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,577
Medicare services
Top 19% in CA for neurology
1,418
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~136 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
949 | $101 | $226 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
500 | $104 | $240 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
430 | $66 | $158 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
277 | $137 | $440 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
205 | $142 | $322 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
94 | $176 | $602 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
37 | $47 | $119 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $119 | $363 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
21 | $108 | $285 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $66 | $163 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $111 | $296 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,136
Total received (2018-2024)
Avg $2,448/year across 7 years
Top 17% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
593
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,807 (92.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,174 (6.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$155 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,489
2023
$3,804
2022
$2,167
2021
$2,367
2020
$1,665
2019
$1,453
2018
$1,190
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,705
LivaNova USA, Inc.
$594
ABBVIE INC.
$274
Alexion Pharmaceuticals, Inc.
$240
UCB, Inc.
$227
Novartis Pharmaceuticals Corporation
$224
PFIZER INC.
$178
ARGENX US, INC.
$153
Eisai Inc.
$153
Neurelis, Inc.
$142
Alnylam Pharmaceuticals Inc.
$83
Neurocrine Biosciences, Inc.
$78
Celgene Corporation
$69
ACADIA Pharmaceuticals Inc
$65
Averitas Pharma Inc.
$56
Boston Scientific Corporation
$46
Lilly USA, LLC
$40
MDD US Operations, LLC
$39
Otsuka America Pharmaceutical, Inc.
$28
Biogen, Inc.
$28
InSightec,Inc
$28
Teva Pharmaceuticals USA, Inc.
$21
SK Life Science, Inc.
$19
Top 3 companies account for 57.3% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,960
Sage Therapeutics, Inc.
$1,843
Novartis Pharmaceuticals Corporation
$1,646
ABBVIE INC.
$857
Biogen, Inc.
$790
ACADIA Pharmaceuticals Inc
$672
Dr.Reddy's Laboratories,Inc.
$660
LivaNova USA, Inc.
$637
Alexion Pharmaceuticals, Inc.
$602
Teva Pharmaceuticals USA, Inc.
$575
UCB, Inc.
$572
Neurocrine Biosciences, Inc.
$511
Allergan, Inc.
$424
Alnylam Pharmaceuticals Inc.
$410
Amgen Inc.
$318
AbbVie Inc.
$310
ARGENX US, INC.
$308
Genentech USA, Inc.
$269
Eisai Inc.
$245
Biohaven Pharmaceuticals, Inc.
$238
Lilly USA, LLC
$214
SK Life Science, Inc.
$205
PFIZER INC.
$204
Kyowa Kirin, Inc.
$180
GENZYME CORPORATION
$177
Sunovion Pharmaceuticals Inc.
$158
Neurelis, Inc.
$156
Harmony Biosciences LLC
$121
MDD US Operations, LLC
$117
US WorldMeds, LLC
$115
Genentech, Inc.
$114
Celgene Corporation
$94
Lundbeck LLC
$94
Upsher-Smith Laboratories LLC
$93
Banner Life Sciences, LLC
$77
Allergan Inc.
$69
Boston Scientific Corporation
$64
Adamas Pharmaceuticals, Inc.
$61
CATALYST PHARMACEUTICALS, INC.
$61
NOVARTIS PHARMACEUTICALS CORPORATION
$58
Janssen Pharmaceuticals, Inc
$57
Averitas Pharma Inc.
$56
AstraZeneca Pharmaceuticals LP
$55
EISAI INC.
$49
MITSUBISHI TANABE PHARMA AMERICA, INC.
$47
Avanir Pharmaceuticals, Inc.
$47
Alfasigma USA, Inc.
$45
Acorda Therapeutics, Inc
$41
Vertical Pharmaceuticals, LLC
$36
Grifols USA, LLC
$31
Corium, LLC
$29
Otsuka America Pharmaceutical, Inc.
$28
InSightec,Inc
$28
Greenwich Biosciences, Inc.
$26
Horizon Therapeutics plc
$24
E.R. Squibb & Sons, L.L.C.
$23
SCILEX PHARMACEUTICALS INC.
$21
UPSHER-SMITH LABORATORIES LLC
$20
HARMONY BIOSCIENCES LLC
$20
Chiesi USA, Inc.
$20
ARBOR PHARMACEUTICALS, INC.
$19
Mitsubishi Tanabe Pharma America, Inc.
$19
Scilex Pharmaceuticals Inc.
$19
Mallinckrodt LLC
$18
Medtronic Vascular, Inc.
$16
EMD Serono, Inc.
$16
AbbVie, Inc.
$15
Cala Health, Inc.
$15
Almatica Pharma LLC
$15
Top 3 companies account for 31.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · APOKYN · APTIOM · ARZERRA · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CALA TRIO · CLEVIPREX · COPAXONE · Confirm Rx · DUOPA · Dayvigo · Duopa · EMGALITY · Enspryng · Epidiolex · Exablate · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · Leqembi · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Non-Covered Product · Nourianz · Nuedexta · OCREVUS · ONPATTRO · OSMOLEX ER · Ongentys · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REYVOW · Radicava · Reveal LINQ · SOLIRIS · SPINRAZA · Skyclarys · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · WATCHMAN FLX · Wakix · XADAGO · XARELTO · Xadago · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
385
Per 100K population
12.2
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Omidvar is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 17% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Omidvar experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Omidvar performed 949 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Omidvar receive payments from pharmaceutical companies?
Yes. Dr. Omidvar received a total of $17,136 from 69 companies across 593 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Omidvar's costs compare to other neurologists in Los Alamitos?
Dr. Omidvar's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Omidvar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Los Alamitos
Browse neurologists in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Sage Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Sage Therapeutics, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology